Company / Return on Assets (ROA)
NP Life Sciences Health Industry Group Inc. Return on Assets (ROA) History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-3.8%
FY2023
5-year range
-171.0% / -3.8%
FY2019-FY2023
Trend
+74.1%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -171.0% to -3.8% over the past 2 years.
Based on SEC 10-K filings.
-3.8% in FY2023 with a 3-year CAGR of +106.7%.
Improved from -171.0% to -3.8% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +106.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, return on assets (roa) increased 74.1% year-over-year.
- Lowest return on assets (roa) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2023 | -3.8% | +74.1% |
| FY2022 | -14.8% | +91.4% |
| FY2021 | -171.0% | -54.7% |
| FY2020 | -110.5% | -154.0% |
| FY2019 | -43.5% | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026